Single Nucleus RNA Sequencing (snRNA-seq) is a powerful transcriptomics method that enables gene expression profiling at the resolution of individual cell nuclei. This technique has become essential for studying human brain tissue, particularly in neurodegenerative disease research where fresh tissue is often unavailable[1].
snRNA-seq involves isolating intact nuclei from tissues, followed by RNA extraction and sequencing:
snRNA-seq offers several advantages over other single-cell approaches:
snRNA-seq has revealed distinct transcriptional programs in different brain cell types[2]:
The technique enables identification of:
Integration with genotype data allows[3]:
The Seattle-Alzheimer's Disease Brain Cell Atlas (SEA-AD) has used snRNA-seq to:
snRNA-seq data has contributed to:
| Feature | scRNA-seq | snRNA-seq |
|---|---|---|
| Sample requirement | Fresh tissue | Frozen tissue acceptable |
| Cell types captured | May miss large cells | Captures all sizes |
| Nucleus purity | Not applicable | Critical |
| Gene detection | Full transcriptome | Reduced for some genes |
snRNA-seq complements spatial transcriptomics by providing:
The study of Single Nucleus Rna Sequencing (Snrna Seq) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Single-nucleus RNA sequencing reveals cell type-specific responses in AD brain. 1926. ↩︎
Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. ↩︎
Genetic variant effects on gene expression in the human brain. 2020. ↩︎
High-throughput single-nucleus RNA sequencing of the adult human brain. ↩︎
Single-nucleus RNA sequencing of neocortex from 424 individuals. ↩︎
Microglial states in Alzheimer's disease brain identified by snRNA-seq. ↩︎